SEI Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

SEI Investments’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.1M	Sell	148,927 -39,638	-21%	-$2.92M	0.01%	1067
2026 Q2	$12.1M	Sell	188,565 -95,440	-34%	-$4.95M	0.01%	1042
2026 Q1	$13.7M	Buy	284,005 +66,509	+31%	+$2.95M	0.01%	965
2025 Q4	$8.97M	Buy	217,496 +46,327	+27%	+$1.86M	0.01%	1105
2025 Q3	$6.65M	Buy	171,169 +69,673	+69%	+$2.26M	0.01%	1187
2025 Q2	$2.81M	Buy	101,496 +25,860	+34%	+$658K	﹤0.01%	1511
2025 Q1	$1.68M	Buy	75,636 +33,452	+79%	+$689K	﹤0.01%	1706
2024 Q4	$834K	Sell	42,184 -2,354	-5%	-$53.7K	﹤0.01%	2018
2024 Q3	$1.11M	Buy	44,538 +5,562	+14%	+$135K	﹤0.01%	1911
2024 Q2	$728K	Sell	38,976 -34,505	-47%	-$646K	﹤0.01%	2026
2024 Q1	$1.45M	Buy	+73,481	New	+$1.44M	﹤0.01%	1752
2023 Q4	–	Sell	-20,819	Closed	-$362K	–	2652
2023 Q3	$362K	Buy	+20,819	New	+$351K	﹤0.01%	2232

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

SEI Investments's KNSA Position: Q3 2026 in Review

SEI Investments reduced its Kiniksa Pharmaceuticals (KNSA) stake by 21% in Q3 2026, selling an estimated $2.92M and leaving 148,927 shares worth $11.1M. The position accounts for 0.01% of the portfolio, ranked #1067.

SEI Investments first reported a position in KNSA in Q3 2023 and has held it in 12 quarters since. The position peaked at $13.7M in Q1 2026. 149 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

SEI Investments held 148,927 shares of Kiniksa Pharmaceuticals worth $11.1M as of Q3 2026.
SEI Investments sold 39,638 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $2.92M.
Kiniksa Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q3 2026, its #1067 holding.
SEI Investments first reported a position in Kiniksa Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
SEI Investments's Kiniksa Pharmaceuticals position peaked at $13.7M in Q1 2026.
149 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.